Mandate

Vinge advises BHG Group in acquisition of Nordic Nest

December 14, 2020 Employment and Benefits M&A

Vinge is advising BHG Group AB (publ) in connection with the acquisition of 97.6 per cent of the shares in Nordic Nest Group AB. The acquisition price corresponds to an enterprise value of SEK 1.8 billion.

Nordic Nest offers Scandinavian home decoration design online with customers in 70 countries, including the Nordics, Germany and South Korea. The company has approximately 220 employees and for the split fiscal year 2020/21, which ends on 31 March 2021, net sales are expected to be approximately SEK 1 billion and EBITDA is expected to amount to approximately MSEK 120.

BHG is the largest online actor within consumer trading in the Nordics and the largest actor in Europe within Home improvement, which includes both Do-It-Yourself and Home Furnishings. BHG’s e-trading business has 1,800 employees and includes more than 85 online destinations. The head office is situated in Malmö and the company conducts operations in most European countries. BHG is listed on Nasdaq Stockholm.

 

Vinge’s team consists of Kristian Ford together with, among others, Pär Remnelid, Philip ÅbergTilda HallDaniel Melander Björner and Emelie Svensäter Jerntorp.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025